On November 14, 2019 Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases, cancer, and other indications, reported that members of the management team will participate in the following upcoming investor conferences (Press release, Pieris Pharmaceuticals, NOV 14, 2019, View Source [SID1234551278]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Jefferies 2019 London Healthcare Conference
Wednesday, November 20, 2019 in London. The Company will conduct one-on-one meetings with institutional investors at this conference.
Evercore ISI HealthCONx Conference 2019
Tuesday, December 3, 2019 at 10:35 AM EST in Boston. A webcast of the Company’s presentation will be available at this link.